{ "@graph": [    { "@id": "http://linked.opendata.cz/resource/ATC/H",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Syst\u00E9mov\u00E1 hormon\u00E1ln\u00ED l\u00E9\u010Diva krom\u011B pohlavn\u00EDch hormon\u016F a inzulin\u016F" , "@language" : "cs" } ,        { "@value" : "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "H" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/H01",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Hypofyz\u00E1rn\u00ED a hypotalamick\u00E9 hormony a analogy" , "@language" : "cs" } ,        { "@value" : "PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES" , "@language" : "en" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "H01" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/H01A",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES" , "@language" : "en" } ,        { "@value" : "Hormony p\u0159edn\u00EDho laloku hypof\u00FDzy a analogy" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "H01A" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/H01AC",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Somatropin and analogues" , "@language" : "en" } ,        { "@value" : "Somatropin a agonist\u00E9 somatropinu" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "H01AC" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ATC/H01AC01",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/ATCConcept" ] ,      "http://www.w3.org/2004/02/skos/core#broaderTransitive" : [ "http://linked.opendata.cz/resource/ATC/H01A" ,        "http://linked.opendata.cz/resource/ATC/H" ,        "http://linked.opendata.cz/resource/ATC/H01" ,        "http://linked.opendata.cz/resource/ATC/H01AC" ] ,      "http://purl.org/dc/terms/title" : [ { "@value" : "Somatropin" , "@language" : "en" } ,        { "@value" : "Somatropin" , "@language" : "cs" } ] ,      "http://www.w3.org/2004/02/skos/core#notation" : [ { "@value" : "H01AC01" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000000999",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Drug hypersensitivity" , "@language" : "en" } ,        { "@value" : "L\u00E9kov\u00E1 alergie" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000004102",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Intracranial hemorrhages" , "@language" : "en" } ,        { "@value" : "Intrakrani\u00E1ln\u00ED hemoragie" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/ndfrt/disease/N0000000609",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/DiseaseOrFinding" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "N\u00E1dory mozku" , "@language" : "cs" } ,        { "@value" : "Brain neoplasms" , "@language" : "en" } ] } ,    { "@id": "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0028842",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/Ingredient" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "Human growth hormone" , "@language" : "en" } ,        { "@value" : "Lidsk\u00FD r\u016Fstov\u00FD hormon" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/description" : [ { "@value" : "A 191-amino acid polypeptide hormone secreted by the human adenohypophysis (PITUITARY GLAND, ANTERIOR), also known as GH or somatotropin. Synthetic growth hormone, termed somatropin, has replaced the natural form in therapeutic usage such as treatment of dwarfism in children with growth hormone deficiency.     " , "@language" : "en" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/contraindicatedWith" : [ "http://linked.opendata.cz/resource/ndfrt/disease/N0000004102" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000000609" ,        "http://linked.opendata.cz/resource/ndfrt/disease/N0000000999" ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product/NORDITROPIN-SIMPLEXX-10MG-1-5ML",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProduct" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasActiveIngredient" : [ "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0028842" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "NORDITROPIN SIMPLEXX 10MG/1,5ML" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/H01AC01" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMedicinalProductPackaging" : [ "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0001165" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0014615" ,        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0001166" ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0001165",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "NORDITROPIN SIMPLEXX 10MG/1,5ML" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/H01AC01" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HORMONA (L\u00C9\u010CIVA S HORMON\u00C1LN\u00CD AKTIVITOU)" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC155252_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "1X1.5ML" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Injekce" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "6.7MG/ML" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "D\u011Bti:\nPoruchy r\u016Fstu zp\u016Fsoben\u00E9 nedostatkem r\u016Fstov\u00E9ho hormonu (GHD).\nPoruchy r\u016Fstu u d\u00EDvek s dysgenez\u00ED gon\u00E1d (Turner\u016Fv syndrom)\nZpomalen\u00ED r\u016Fstu u prepubert\u00E1ln\u00EDch d\u011Bt\u00ED zp\u016Fsoben\u00E9 chronick\u00FDm onemocn\u011Bn\u00EDm ledvin.\nPoruchy r\u016Fstu (sou\u010Dasn\u00E9 sk\u00F3re sm\u011Brodatn\u00E9 odchylky (SDS) v\u00FD\u0161ky <-2,5 a na v\u00FD\u0161ku rodi\u010D\u016F korigovan\u00E9 SDS v\u00FD\u0161ky <-1) u d\u011Bt\u00ED mal\u00E9ho vzr\u016Fstu narozen\u00FDch jako mal\u00E9 vzhledem ke gesta\u010Dn\u00EDmu v\u011Bku s\u00A0porodn\u00ED v\u00E1hou a/nebo v\u00FD\u0161kou ni\u017E\u0161\u00ED ne\u017E -2 SD, u nich\u017E nen\u00ED patrn\u00FD r\u016Fstov\u00FD v\u00FD\u0161vih (SDS r\u016Fstov\u00E9 rychlosti < 0 b\u011Bhem posledn\u00EDho roku) do 4 let v\u011Bku nebo pozd\u011Bji.\nDosp\u011Bl\u00ED:\nNedostate\u010Dnost r\u016Fstov\u00E9ho hormonu vznikl\u00E1 v\u00A0d\u011Btstv\u00ED:\nU pacient\u016F s\u00A0nedostatkem r\u016Fstov\u00E9ho hormonu vznikl\u00FDm v\u00A0d\u011Btstv\u00ED by po dovr\u0161en\u00ED r\u016Fstu m\u011Bla b\u00FDt znovu zhodnocena sekre\u010Dn\u00ED kapacita. Test nen\u00ED vy\u017Eadov\u00E1n u pacient\u016F s\u00A0nedostatkem v\u00EDce ne\u017E t\u0159\u00ED hypofyz\u00E1rn\u00EDch hormon\u016F, u pacient\u016F se z\u00E1va\u017En\u00FDm nedostatkem r\u016Fstov\u00E9ho hormonu v\u00A0d\u016Fsledku definovan\u00E9 genetick\u00E9 p\u0159\u00ED\u010Diny, v\u00A0d\u016Fsledku struktur\u00E1ln\u00EDch hypotalamo-hypofyz\u00E1rn\u00EDch abnormalit, v\u00A0d\u016Fsledku n\u00E1dor\u016F centr\u00E1ln\u00ED nervov\u00E9 soustavy nebo v\u00A0d\u016Fsledku vysok\u00FDch d\u00E1vek p\u0159i oz\u00E1\u0159en\u00ED v\u00A0oblasti hlavy \u010Di u pacient\u016F se sekund\u00E1rn\u00EDm nedostatkem r\u016Fstov\u00E9ho hormonu k hypotalamo-hypofyz\u00E1rn\u00EDmu onemocn\u011Bn\u00ED \u010Di po\u0161kozen\u00ED, pokud byly nam\u011B\u0159eny hodnoty IGF-I <-2 SDS po minim\u00E1ln\u011B \u010Dty\u0159ech t\u00FDdnech l\u00E9\u010Dby r\u016Fstov\u00FDm hormonem.\nU v\u0161ech ostatn\u00EDch pacient\u016F je vy\u017Eadov\u00E1no stanoven\u00ED hladin IGF-I a jeden stimula\u010Dn\u00ED test r\u016Fstov\u00FDm hormonem.\nNedostate\u010Dnost r\u016Fstov\u00E9ho hormonu vznikl\u00E1 v\u00A0dosp\u011Blosti:\nV\u00FDrazn\u00FD deficit r\u016Fstov\u00E9ho hormonu p\u0159i zn\u00E1m\u00E9m hypotalamo-hypofyz\u00E1rn\u00EDm onemocn\u011Bn\u00ED, oz\u00E1\u0159en\u00ED v\u00A0oblasti hlavy a traumatick\u00E9 poran\u011Bn\u00ED mozku. Nedostatek r\u016Fstov\u00E9ho hormonu by m\u011Bl b\u00FDt spojen s deficitem je\u0161t\u011B v jin\u00E9 ose krom\u011B prolaktinu. Nedostatek r\u016Fstov\u00E9ho hormonu by m\u011Bl b\u00FDt prok\u00E1z\u00E1n jedn\u00EDm stimula\u010Dn\u00EDm testem. Testov\u00E1n\u00ED deficitu r\u016Fstov\u00E9ho hormonu by m\u011Blo b\u00FDt prov\u00E1d\u011Bno po zaveden\u00ED adekv\u00E1tn\u00ED substituce v ka\u017Ed\u00E9 deficitn\u00ED ose.\nU dosp\u011Bl\u00FDch je test inzulinov\u00E9 tolerance stimula\u010Dn\u00EDm testem volby. Je-li test inzulinov\u00E9 tolerance kontraindikov\u00E1n, je t\u0159eba pou\u017E\u00EDt alternativn\u00ED stimula\u010Dn\u00ED testy. Doporu\u010Duje se kombinovan\u00FD arginin-r\u016Fstov\u00FD hormon uvol\u0148uj\u00EDc\u00ED hormon. Lze tak\u00E9 uva\u017Eovat o argininov\u00E9m nebo glukagonov\u00E9m testu, nicm\u00E9n\u011B diagnostick\u00E1 hodnota t\u011Bchto test\u016F je men\u0161\u00ED ne\u017E u testu inzulinov\u00E9 tolerance.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasMaximalPrice" : [ { "@value" : 10209.6298828125 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasReimbursementAmount" : [ { "@value" : 7768.75 , "@type" : "http://www.w3.org/2001/XMLSchema#float" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "INJ SOL 1X1.5ML/10MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0014615",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "NORDITROPIN SIMPLEXX 10MG/1,5ML" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/H01AC01" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HORMONA (L\u00C9\u010CIVA S HORMON\u00C1LN\u00CD AKTIVITOU)" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC155252_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "5X1.5ML" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Injekce" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "6.7MG/ML" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "D\u011Bti:\nPoruchy r\u016Fstu zp\u016Fsoben\u00E9 nedostatkem r\u016Fstov\u00E9ho hormonu (GHD).\nPoruchy r\u016Fstu u d\u00EDvek s dysgenez\u00ED gon\u00E1d (Turner\u016Fv syndrom)\nZpomalen\u00ED r\u016Fstu u prepubert\u00E1ln\u00EDch d\u011Bt\u00ED zp\u016Fsoben\u00E9 chronick\u00FDm onemocn\u011Bn\u00EDm ledvin.\nPoruchy r\u016Fstu (sou\u010Dasn\u00E9 sk\u00F3re sm\u011Brodatn\u00E9 odchylky (SDS) v\u00FD\u0161ky <-2,5 a na v\u00FD\u0161ku rodi\u010D\u016F korigovan\u00E9 SDS v\u00FD\u0161ky <-1) u d\u011Bt\u00ED mal\u00E9ho vzr\u016Fstu narozen\u00FDch jako mal\u00E9 vzhledem ke gesta\u010Dn\u00EDmu v\u011Bku s\u00A0porodn\u00ED v\u00E1hou a/nebo v\u00FD\u0161kou ni\u017E\u0161\u00ED ne\u017E -2 SD, u nich\u017E nen\u00ED patrn\u00FD r\u016Fstov\u00FD v\u00FD\u0161vih (SDS r\u016Fstov\u00E9 rychlosti < 0 b\u011Bhem posledn\u00EDho roku) do 4 let v\u011Bku nebo pozd\u011Bji.\nDosp\u011Bl\u00ED:\nNedostate\u010Dnost r\u016Fstov\u00E9ho hormonu vznikl\u00E1 v\u00A0d\u011Btstv\u00ED:\nU pacient\u016F s\u00A0nedostatkem r\u016Fstov\u00E9ho hormonu vznikl\u00FDm v\u00A0d\u011Btstv\u00ED by po dovr\u0161en\u00ED r\u016Fstu m\u011Bla b\u00FDt znovu zhodnocena sekre\u010Dn\u00ED kapacita. Test nen\u00ED vy\u017Eadov\u00E1n u pacient\u016F s\u00A0nedostatkem v\u00EDce ne\u017E t\u0159\u00ED hypofyz\u00E1rn\u00EDch hormon\u016F, u pacient\u016F se z\u00E1va\u017En\u00FDm nedostatkem r\u016Fstov\u00E9ho hormonu v\u00A0d\u016Fsledku definovan\u00E9 genetick\u00E9 p\u0159\u00ED\u010Diny, v\u00A0d\u016Fsledku struktur\u00E1ln\u00EDch hypotalamo-hypofyz\u00E1rn\u00EDch abnormalit, v\u00A0d\u016Fsledku n\u00E1dor\u016F centr\u00E1ln\u00ED nervov\u00E9 soustavy nebo v\u00A0d\u016Fsledku vysok\u00FDch d\u00E1vek p\u0159i oz\u00E1\u0159en\u00ED v\u00A0oblasti hlavy \u010Di u pacient\u016F se sekund\u00E1rn\u00EDm nedostatkem r\u016Fstov\u00E9ho hormonu k hypotalamo-hypofyz\u00E1rn\u00EDmu onemocn\u011Bn\u00ED \u010Di po\u0161kozen\u00ED, pokud byly nam\u011B\u0159eny hodnoty IGF-I <-2 SDS po minim\u00E1ln\u011B \u010Dty\u0159ech t\u00FDdnech l\u00E9\u010Dby r\u016Fstov\u00FDm hormonem.\nU v\u0161ech ostatn\u00EDch pacient\u016F je vy\u017Eadov\u00E1no stanoven\u00ED hladin IGF-I a jeden stimula\u010Dn\u00ED test r\u016Fstov\u00FDm hormonem.\nNedostate\u010Dnost r\u016Fstov\u00E9ho hormonu vznikl\u00E1 v\u00A0dosp\u011Blosti:\nV\u00FDrazn\u00FD deficit r\u016Fstov\u00E9ho hormonu p\u0159i zn\u00E1m\u00E9m hypotalamo-hypofyz\u00E1rn\u00EDm onemocn\u011Bn\u00ED, oz\u00E1\u0159en\u00ED v\u00A0oblasti hlavy a traumatick\u00E9 poran\u011Bn\u00ED mozku. Nedostatek r\u016Fstov\u00E9ho hormonu by m\u011Bl b\u00FDt spojen s deficitem je\u0161t\u011B v jin\u00E9 ose krom\u011B prolaktinu. Nedostatek r\u016Fstov\u00E9ho hormonu by m\u011Bl b\u00FDt prok\u00E1z\u00E1n jedn\u00EDm stimula\u010Dn\u00EDm testem. Testov\u00E1n\u00ED deficitu r\u016Fstov\u00E9ho hormonu by m\u011Blo b\u00FDt prov\u00E1d\u011Bno po zaveden\u00ED adekv\u00E1tn\u00ED substituce v ka\u017Ed\u00E9 deficitn\u00ED ose.\nU dosp\u011Bl\u00FDch je test inzulinov\u00E9 tolerance stimula\u010Dn\u00EDm testem volby. Je-li test inzulinov\u00E9 tolerance kontraindikov\u00E1n, je t\u0159eba pou\u017E\u00EDt alternativn\u00ED stimula\u010Dn\u00ED testy. Doporu\u010Duje se kombinovan\u00FD arginin-r\u016Fstov\u00FD hormon uvol\u0148uj\u00EDc\u00ED hormon. Lze tak\u00E9 uva\u017Eovat o argininov\u00E9m nebo glukagonov\u00E9m testu, nicm\u00E9n\u011B diagnostick\u00E1 hodnota t\u011Bchto test\u016F je men\u0161\u00ED ne\u017E u testu inzulinov\u00E9 tolerance.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "INJ SOL 5X1.5ML/10MG" , "@language" : "cs" } ] } ,    { "@id": "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0001166",      "@type" : [ "http://linked.opendata.cz/ontology/drug-encyclopedia/MedicinalProductPackaging" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/title" : [ { "@value" : "NORDITROPIN SIMPLEXX 10MG/1,5ML" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasATCConcept" : [ "http://linked.opendata.cz/resource/ATC/H01AC01" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndicationGroup" : [ { "@value" : "HORMONA (L\u00C9\u010CIVA S HORMON\u00C1LN\u00CD AKTIVITOU)" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasSPCDocument" : [ "http://linked.opendata.cz/resource/sukl/spc/document/SPC155252_doc" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasPackagingSize" : [ { "@value" : "3X1.5ML" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRouteOfAdministration" : [ { "@value" : "Injekce" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasStrength" : [ { "@value" : "6.7MG/ML" , "@type" : "http://www.w3.org/2001/XMLSchema#string" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasIndication" : [ { "@value" : "D\u011Bti:\nPoruchy r\u016Fstu zp\u016Fsoben\u00E9 nedostatkem r\u016Fstov\u00E9ho hormonu (GHD).\nPoruchy r\u016Fstu u d\u00EDvek s dysgenez\u00ED gon\u00E1d (Turner\u016Fv syndrom)\nZpomalen\u00ED r\u016Fstu u prepubert\u00E1ln\u00EDch d\u011Bt\u00ED zp\u016Fsoben\u00E9 chronick\u00FDm onemocn\u011Bn\u00EDm ledvin.\nPoruchy r\u016Fstu (sou\u010Dasn\u00E9 sk\u00F3re sm\u011Brodatn\u00E9 odchylky (SDS) v\u00FD\u0161ky <-2,5 a na v\u00FD\u0161ku rodi\u010D\u016F korigovan\u00E9 SDS v\u00FD\u0161ky <-1) u d\u011Bt\u00ED mal\u00E9ho vzr\u016Fstu narozen\u00FDch jako mal\u00E9 vzhledem ke gesta\u010Dn\u00EDmu v\u011Bku s\u00A0porodn\u00ED v\u00E1hou a/nebo v\u00FD\u0161kou ni\u017E\u0161\u00ED ne\u017E -2 SD, u nich\u017E nen\u00ED patrn\u00FD r\u016Fstov\u00FD v\u00FD\u0161vih (SDS r\u016Fstov\u00E9 rychlosti < 0 b\u011Bhem posledn\u00EDho roku) do 4 let v\u011Bku nebo pozd\u011Bji.\nDosp\u011Bl\u00ED:\nNedostate\u010Dnost r\u016Fstov\u00E9ho hormonu vznikl\u00E1 v\u00A0d\u011Btstv\u00ED:\nU pacient\u016F s\u00A0nedostatkem r\u016Fstov\u00E9ho hormonu vznikl\u00FDm v\u00A0d\u011Btstv\u00ED by po dovr\u0161en\u00ED r\u016Fstu m\u011Bla b\u00FDt znovu zhodnocena sekre\u010Dn\u00ED kapacita. Test nen\u00ED vy\u017Eadov\u00E1n u pacient\u016F s\u00A0nedostatkem v\u00EDce ne\u017E t\u0159\u00ED hypofyz\u00E1rn\u00EDch hormon\u016F, u pacient\u016F se z\u00E1va\u017En\u00FDm nedostatkem r\u016Fstov\u00E9ho hormonu v\u00A0d\u016Fsledku definovan\u00E9 genetick\u00E9 p\u0159\u00ED\u010Diny, v\u00A0d\u016Fsledku struktur\u00E1ln\u00EDch hypotalamo-hypofyz\u00E1rn\u00EDch abnormalit, v\u00A0d\u016Fsledku n\u00E1dor\u016F centr\u00E1ln\u00ED nervov\u00E9 soustavy nebo v\u00A0d\u016Fsledku vysok\u00FDch d\u00E1vek p\u0159i oz\u00E1\u0159en\u00ED v\u00A0oblasti hlavy \u010Di u pacient\u016F se sekund\u00E1rn\u00EDm nedostatkem r\u016Fstov\u00E9ho hormonu k hypotalamo-hypofyz\u00E1rn\u00EDmu onemocn\u011Bn\u00ED \u010Di po\u0161kozen\u00ED, pokud byly nam\u011B\u0159eny hodnoty IGF-I <-2 SDS po minim\u00E1ln\u011B \u010Dty\u0159ech t\u00FDdnech l\u00E9\u010Dby r\u016Fstov\u00FDm hormonem.\nU v\u0161ech ostatn\u00EDch pacient\u016F je vy\u017Eadov\u00E1no stanoven\u00ED hladin IGF-I a jeden stimula\u010Dn\u00ED test r\u016Fstov\u00FDm hormonem.\nNedostate\u010Dnost r\u016Fstov\u00E9ho hormonu vznikl\u00E1 v\u00A0dosp\u011Blosti:\nV\u00FDrazn\u00FD deficit r\u016Fstov\u00E9ho hormonu p\u0159i zn\u00E1m\u00E9m hypotalamo-hypofyz\u00E1rn\u00EDm onemocn\u011Bn\u00ED, oz\u00E1\u0159en\u00ED v\u00A0oblasti hlavy a traumatick\u00E9 poran\u011Bn\u00ED mozku. Nedostatek r\u016Fstov\u00E9ho hormonu by m\u011Bl b\u00FDt spojen s deficitem je\u0161t\u011B v jin\u00E9 ose krom\u011B prolaktinu. Nedostatek r\u016Fstov\u00E9ho hormonu by m\u011Bl b\u00FDt prok\u00E1z\u00E1n jedn\u00EDm stimula\u010Dn\u00EDm testem. Testov\u00E1n\u00ED deficitu r\u016Fstov\u00E9ho hormonu by m\u011Blo b\u00FDt prov\u00E1d\u011Bno po zaveden\u00ED adekv\u00E1tn\u00ED substituce v ka\u017Ed\u00E9 deficitn\u00ED ose.\nU dosp\u011Bl\u00FDch je test inzulinov\u00E9 tolerance stimula\u010Dn\u00EDm testem volby. Je-li test inzulinov\u00E9 tolerance kontraindikov\u00E1n, je t\u0159eba pou\u017E\u00EDt alternativn\u00ED stimula\u010Dn\u00ED testy. Doporu\u010Duje se kombinovan\u00FD arginin-r\u016Fstov\u00FD hormon uvol\u0148uj\u00EDc\u00ED hormon. Lze tak\u00E9 uva\u017Eovat o argininov\u00E9m nebo glukagonov\u00E9m testu, nicm\u00E9n\u011B diagnostick\u00E1 hodnota t\u011Bchto test\u016F je men\u0161\u00ED ne\u017E u testu inzulinov\u00E9 tolerance.\n" , "@language" : "cs" } ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasRegistrationState" : [ "http://linked.opendata.cz/resource/sukl/registration-state/R" ] ,      "http://linked.opendata.cz/ontology/drug-encyclopedia/hasTitleSupplement" : [ { "@value" : "INJ SOL 3X1.5ML/10MG" , "@language" : "cs" } ] }] }